Black Diamond Therapeutics, Inc. (BDTX) NASDAQ
2.86
+0(+0.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.86
+0(+0.00%)
Currency In USD
| Market Cap | 138.19M |
| Enterprise Value | 132.27M |
| P/E Ratio | -3.79 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.57 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.76 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.33 |
| Return On Equity | -0.36 |
| Revenue | 70M |
| Revenue/Share | 0 |
| Gross Profit | 69.68M |
| EBITDA | 20.2M |
| Net Income | 22.37M |
| Diluted EPS | 0.39 |
| Total Cash | 118.26M |
| Total Cash/Share | 2.07 |
| Total Debt | 17.88M |
| Total Debt/Equity | 0.17 |
| Current Ratio | 8.46 |
| Book Value Per Share | 1.82 |
| 52-Week Change | 48.19 |
| 52-Week High | 4.94 |
| 52-Week Low | 1.88 |
| Moving Average 50 Days | 2.54 |
| Moving Average 200 Days | 2.94 |
| Average Volume | 744,125 |
| Shares Outstanding | 57.3M |
| % Held by Institutions | 4.48 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |